Searched for
BIOCON BIOLOGICS REVENUE
Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...30 Apr, 2026, 12.49 PM IST- With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...08 Apr, 2026, 12.38 AM IST
- Biocon reports 95% YoY decline in net profit, operating revenue up 15%Biocon's Q1 net profit declined 95% year-on-year, but on a like-for-like basis, profit after tax increased by 65%. Revenue grew 15% to Rs 3...08 Aug, 2025, 06.19 AM IST
- Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiaryBiocon share price: Biocon reported a 96% year-on-year (YoY) decline in net profit, which fell to Rs 25 crore in Q3FY25. In comparison, the...31 Jan, 2025, 09.12 AM IST
- Biocon arm's growth formula: US rollouts & debt reductionBiocon Biologics planned to introduce six new biosimilar products in the US in the next two years, subject to regulatory approval. They emp...12 Aug, 2024, 11.56 PM IST
- Biocon Biologics has comprehensive plan to integrate Viatris business: Shreehas Tambe, Biocon Biologics"There are several other discussions that we have been having with private equity investors who are interested in making an investment in B...16 Feb, 2023, 12.47 AM IST
- Biocon completes $3.34 billion acquisition of Viatris's biosimilar businessTo fund the upfront payment, Biocon Biologics has secured $1.2 billion of Sustainability Linked Loan (SLL). The balance has been funded thr...29 Nov, 2022, 07.24 PM IST
- Biocon Biologics expects big gains from integration of Viatris business, SII dealBiocon Biologics in March entered into a definitive agreement to acquire Viatris' biosimilars assets for $3.34 billion. It will pay Viatris...09 Jun, 2022, 12.36 AM IST
- Biocon Q4 Results: Profit declines 4% to Rs 283 crConsolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period, it...28 Apr, 2022, 11.11 PM IST
- Biocon Q3 Results: Net profit rises 11% YoY to Rs 187 croreThe earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third qua...21 Jan, 2022, 11.16 AM IST
- Tata Capital picks up 0.85% stake in Biocon Biologics for $30 millionPost the completion of this transaction, Biocon will hold a 95.25 per cent stake in Biocon Biologics.31 Jul, 2020, 09.35 AM IST
- Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-ShawIt looks to build a pipeline of 28 biosimilars across global markets in three phases.27 Jan, 2020, 07.41 AM IST
- Biocon elevates M B Chinappa as CFO of biosimilar subsidiaryM B Chinappa, who is going to play an important role in Biocon Biologics’ journey towards becoming a global leader in biologics, has been t...06 Jan, 2020, 07.56 PM IST
- True North to acquire 2.4% stake in Biocon BiologicsDeal values Biocon Biologics at $3 billion06 Jan, 2020, 07.51 PM IST
- True North buys into Biocon Biologics, deal values firm at around $3.5 billionTrue North has acquired about 3 per cent of Biocon Biologics India Ltd (BBIL), a wholly owned subsidiary of Biocon, for $100 million, valui...06 Jan, 2020, 08.59 AM IST
- Biocon reports 64% jump in Q4 net riding on biologicsBiocon reported a 64 per cent jump in its net profit for the quarter ending March 2019.30 Apr, 2019, 08.10 AM IST
- Biocon posts 52% rise in net profit in Q2Expansion of its biologics footprint in emerging markets and licensing agreements boosted the revenue further, according to the company’s m...20 Oct, 2016, 10.37 PM IST
Load More
